The purpose of this study is to compare Budesonide/formoterol Easyhaler test products with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Orion Pharma, Clinical Pharmacology Unit
Espoo, Finland
Cmax of plasma budesonide and formoterol
Time frame: within 24 hours
AUCt of plasma budesonide and formoterol
Time frame: within 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.